neurocare

Munich, Germany · Founded 2014 · Acquired/Merged

Developer of a digital therapy platform (DTP) designed to empower clinicians to deliver best practices. neurocare is based in Munich, Germany and was founded in 2014. Its last known valuation is $75.8 million (Jan 2024). It has raised $20 million.

Last price · $/share
—
Implied valuation
$75.8M
Total raised
$20.0M
Last round
—

Who backs neurocare?

13 investors
InvestorType
Plutus Investment GroupFamily office
Additio Investment Group—
Aescuvest—
Convergence Partners (Switzerland)—
Impact Expansion—
Kyowa Pharmaceutical—
Palo Santo—
TVM Capital Healthcare Partners—
Treuenburg Group—
Twip Impact Ventures—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

neurocare investors

13 investors are on record for neurocare, including Plutus Investment Group, Additio Investment Group, Aescuvest and Convergence Partners (Switzerland).

Free account
More of neurocare with a free account
  • ·The complete investor list: 13 names
  • ·Watch neurocare: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like neurocare. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View